“We found that PCDs effectively improved the symptoms associated with RLS. The excerpt below sums up the authors’ conclusions: Eliasson entitled “Pneumatic Compression Devices are an Effective Therapy for Restless Legs Syndrome,” concludes very positive findings. The article, co-authored by Christopher J. They help get fluid moving from the legs back towards the heart, encouraging better circulation and, as the studies have concluded, reducing or eliminating the RLS symptoms.Īn article written in the January, 2009 issue of CHEST, the official publication of the American College of Chest Physicians, discussed encouraging results for patients with Restless Legs Syndrome. Pneumatic Compression Devices, such as SCD machines, are designed to help patients who have a compromised circulatory or lymphatic system. The medical community, searching for another answer, has begun studying how Pneumatic Compression Devices (PCDs) might help RLS patients. As is the case with all medication, there are potential adverse side effects that may change the patient’s desire to take what they have been prescribed. Many patients who are diagnosed with RLS are treated with various forms of medication. Patients who suffer from Restless Legs Syndrome usually become more inactive which can be detrimental to their quality of life. Typical symptoms of RLS include tingling of the legs, difficulty sleeping and lying down, and leg discomfort, often extreme. However, science has not been able to pinpoint the exact cause of RLS as of yet. Studies are showing that the cause of Restless Legs Syndrome is neurological in nature. Women, however, are two to three times more likely than men to have RLS, and most people find that their symptoms worsen over time. RLS is considered a life-long condition and will affect both men and women regardless of age. Estimates of people living with RLS in the United States are in the 10% range, with up to 3% having moderate or severe symptoms (3-4 symptomatic episodes occuring per week). Transdermal oestradiol is ineffective for PLMD.The diagnosis of Restless Legs Syndrome (RLS) is more prevalent today than ever. The following level A recommendations can be offered: for primary RLS, cabergoline, gabapentin, pergolide, ropinirole, levodopa and rotigotine by transdermal delivery (the latter two for short-term use) are effective in relieving the symptoms. No controlled trials were available for RLS in children and for RLS during pregnancy. Reported adverse events were usually mild and reversible augmentation was a feature with dopaminergic agents. Dopaminergic agents came out as having the best evidence for efficacy in primary RLS. All trials were analysed according to class of evidence, and recommendations formed according to the 2004 EFNS criteria for rating. After determining the objectives for management and the search strategy for primary and secondary RLS and for PLMD, a review of the scientific literature up to 2004 was performed for the drug classes and interventions employed in treatment (drugs acting on the adrenoreceptor, antiepileptic drugs, benzodiazepines/hypnotics, dopaminergic agents, opioids, other treatments). In 2003, the EFNS Task Force was set up for putting forth guidelines for the management of the Restless Legs Syndrome (RLS) and the Periodic Limb Movement Disorder (PLMD).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |